129 related articles for article (PubMed ID: 38022846)
1. Impact of digital positron emission tomography/computed tomography on the delineation of clinical target volume in advanced lung cancer.
Makita K; Hamamoto Y; Kanzaki H; Nagasaki K; Miyagawa M; Kawaguchi N; Okada T; Kido T; Kozuki T
Mol Clin Oncol; 2023 Dec; 19(6):102. PubMed ID: 38022846
[TBL] [Abstract][Full Text] [Related]
2. Performance of digital PET/CT compared with conventional PET/CT in oncologic patients: a prospective comparison study.
de Jong TL; Koopman D; van Dalen JA; Tegelaar A; van Dijk JD; Stevens H; Jager PL
Ann Nucl Med; 2022 Aug; 36(8):756-764. PubMed ID: 35727433
[TBL] [Abstract][Full Text] [Related]
3. Increased
Meyer M; Allenbach G; Nicod Lalonde M; Schaefer N; Prior JO; Gnesin S
Sci Rep; 2020 Jan; 10(1):368. PubMed ID: 31942032
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer.
Vinod SK; Kumar S; Holloway LC; Shafiq J
J Med Imaging Radiat Oncol; 2010 Apr; 54(2):152-60. PubMed ID: 20518880
[TBL] [Abstract][Full Text] [Related]
5. Performance of Digital PET Compared with High-Resolution Conventional PET in Patients with Cancer.
Koopman D; van Dalen JA; Stevens H; Slump CH; Knollema S; Jager PL
J Nucl Med; 2020 Oct; 61(10):1448-1454. PubMed ID: 32060217
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
[TBL] [Abstract][Full Text] [Related]
7. Comparison of
Walacides D; Meier A; Knöchelmann AC; Meinecke D; Derlin T; Bengel FM; Ross TL; Wester HJ; Derlin K; Kuczyk MA; von Klot CAJ; Christiansen H; Henkenberens C
Strahlenther Onkol; 2019 May; 195(5):420-429. PubMed ID: 30610354
[TBL] [Abstract][Full Text] [Related]
8. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis.
Steenbakkers RJ; Duppen JC; Fitton I; Deurloo KE; Zijp LJ; Comans EF; Uitterhoeve AL; Rodrigus PT; Kramer GW; Bussink J; De Jaeger K; Belderbos JS; Nowak PJ; van Herk M; Rasch CR
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):435-48. PubMed ID: 16198064
[TBL] [Abstract][Full Text] [Related]
9. 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiotherapy target volume definition in non-small-cell lung cancer: delineation by radiation oncologists vs. joint outlining with a PET radiologist?
Hanna GG; Carson KJ; Lynch T; McAleese J; Cosgrove VP; Eakin RL; Stewart DP; Zatari A; O'Sullivan JM; Hounsell AR
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1040-51. PubMed ID: 20350798
[TBL] [Abstract][Full Text] [Related]
10. Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.
Karki K; Saraiya S; Hugo GD; Mukhopadhyay N; Jan N; Schuster J; Schutzer M; Fahrner L; Groves R; Olsen KM; Ford JC; Weiss E
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):80-89. PubMed ID: 28816167
[TBL] [Abstract][Full Text] [Related]
11. Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability: PET/CT improves esophageal target definition.
Schreurs LM; Busz DM; Paardekooper GM; Beukema JC; Jager PL; Van der Jagt EJ; van Dam GM; Groen H; Plukker JT; Langendijk JA
Dis Esophagus; 2010 Aug; 23(6):493-501. PubMed ID: 20113320
[TBL] [Abstract][Full Text] [Related]
12. Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot study.
Liu J; Li C; Hu M; Lu J; Shi X; Xing L; Sun X; Fu Z; Yu J; Meng X
Medicine (Baltimore); 2015 May; 94(17):e678. PubMed ID: 25929896
[TBL] [Abstract][Full Text] [Related]
13. Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy.
Leclerc M; Lartigau E; Lacornerie T; Daisne JF; Kramar A; Grégoire V
Radiother Oncol; 2015 Jul; 116(1):87-93. PubMed ID: 26088157
[TBL] [Abstract][Full Text] [Related]
14. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
[TBL] [Abstract][Full Text] [Related]
15. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Cancer Radiother; 2005 Sep; 9(5):304-15. PubMed ID: 16087377
[TBL] [Abstract][Full Text] [Related]
16. Impact of integrated PET/CT on variability of target volume delineation in rectal cancer.
Patel DA; Chang ST; Goodman KA; Quon A; Thorndyke B; Gambhir SS; McMillan A; Loo BW; Koong AC
Technol Cancer Res Treat; 2007 Feb; 6(1):31-6. PubMed ID: 17241098
[TBL] [Abstract][Full Text] [Related]
17. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
18. ¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer.
Delouya G; Igidbashian L; Houle A; Bélair M; Boucher L; Cohade C; Beaulieu S; Filion EJ; Coulombe G; Hinse M; Martel C; Després P; Nguyen-Tan PF
Radiother Oncol; 2011 Dec; 101(3):362-8. PubMed ID: 21885143
[TBL] [Abstract][Full Text] [Related]
19. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
[TBL] [Abstract][Full Text] [Related]
20. A Prospective Study Comparing Functional Imaging (
Prathipati A; Manthri RG; Subramanian BV; Das P; Jilla S; Mani S; J AK; Sarala S; Kottu R; Kalawat TC; Naidu KVJR
Asia Ocean J Nucl Med Biol; 2017; 5(2):75-84. PubMed ID: 28660217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
